Logo image of LINE

LINEAGE INC (LINE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LINE - US53566V1061 - REIT

35 USD
-0.52 (-1.46%)
Last: 12/31/2025, 8:12:11 PM
35 USD
0 (0%)
After Hours: 12/31/2025, 8:12:11 PM
Fundamental Rating

2

Overall LINE gets a fundamental rating of 2 out of 10. We evaluated LINE against 127 industry peers in the Diversified REITs industry. Both the profitability and financial health of LINE have multiple concerns. LINE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LINE has reported negative net income.
In the past year LINE had a positive cash flow from operations.
LINE Yearly Net Income VS EBIT VS OCF VS FCFLINE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

With a Return On Assets value of -0.71%, LINE is not doing good in the industry: 64.57% of the companies in the same industry are doing better.
The Return On Equity of LINE (-1.63%) is worse than 63.78% of its industry peers.
LINE has a worse Return On Invested Capital (1.04%) than 81.89% of its industry peers.
LINE had an Average Return On Invested Capital over the past 3 years of 1.85%. This is in line with the industry average of 3.06%.
Industry RankSector Rank
ROA -0.71%
ROE -1.63%
ROIC 1.04%
ROA(3y)-1.51%
ROA(5y)N/A
ROE(3y)-3.64%
ROE(5y)N/A
ROIC(3y)1.85%
ROIC(5y)N/A
LINE Yearly ROA, ROE, ROICLINE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 -4 -6 -8

1.3 Margins

Looking at the Operating Margin, with a value of 4.39%, LINE is doing worse than 85.83% of the companies in the same industry.
LINE's Operating Margin has been stable in the last couple of years.
LINE has a Gross Margin of 32.18%. This is amonst the worse of the industry: LINE underperforms 86.61% of its industry peers.
LINE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.39%
PM (TTM) N/A
GM 32.18%
OM growth 3Y0.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
LINE Yearly Profit, Operating, Gross MarginsLINE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LINE is destroying value.
LINE has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, LINE has an improved debt to assets ratio.
LINE Yearly Shares OutstandingLINE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M
LINE Yearly Total Debt VS Total AssetsLINE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

LINE has an Altman-Z score of 0.59. This is a bad value and indicates that LINE is not financially healthy and even has some risk of bankruptcy.
LINE's Altman-Z score of 0.59 is in line compared to the rest of the industry. LINE outperforms 55.12% of its industry peers.
The Debt to FCF ratio of LINE is 42.62, which is on the high side as it means it would take LINE, 42.62 years of fcf income to pay off all of its debts.
LINE has a better Debt to FCF ratio (42.62) than 71.65% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that LINE is somewhat dependend on debt financing.
LINE's Debt to Equity ratio of 0.85 is fine compared to the rest of the industry. LINE outperforms 68.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 42.62
Altman-Z 0.59
ROIC/WACC0.14
WACC7.18%
LINE Yearly LT Debt VS Equity VS FCFLINE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

LINE has a Current Ratio of 0.99. This is a bad value and indicates that LINE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of LINE (0.99) is comparable to the rest of the industry.
A Quick Ratio of 0.86 indicates that LINE may have some problems paying its short term obligations.
LINE's Quick ratio of 0.86 is in line compared to the rest of the industry. LINE outperforms 48.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.86
LINE Yearly Current Assets VS Current LiabilitesLINE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500M 1B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.00% over the past year.
Looking at the last year, LINE shows a very negative growth in Revenue. The Revenue has decreased by -42.65% in the last year.
Measured over the past years, LINE shows a quite strong growth in Revenue. The Revenue has been growing by 12.99% on average per year.
EPS 1Y (TTM)82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.25%
Revenue 1Y (TTM)-42.65%
Revenue growth 3Y12.99%
Revenue growth 5YN/A
Sales Q2Q%3.15%

3.2 Future

Based on estimates for the next years, LINE will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.73% on average per year.
The Revenue is expected to grow by 6.68% on average over the next years.
EPS Next Y76.7%
EPS Next 2Y35.99%
EPS Next 3Y23.03%
EPS Next 5Y17.73%
Revenue Next Year1.18%
Revenue Next 2Y1.97%
Revenue Next 3Y2.77%
Revenue Next 5Y6.68%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LINE Yearly Revenue VS EstimatesLINE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
LINE Yearly EPS VS EstimatesLINE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LINE. In the last year negative earnings were reported.
Also next year LINE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LINE Price Earnings VS Forward Price EarningsLINE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

63.78% of the companies in the same industry are more expensive than LINE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, LINE is valued a bit cheaper than 66.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 47
EV/EBITDA 13.34
LINE Per share dataLINE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

LINE's earnings are expected to grow with 23.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.99%
EPS Next 3Y23.03%

4

5. Dividend

5.1 Amount

LINE has a Yearly Dividend Yield of 6.01%, which is a nice return.
Compared to an average industry Dividend Yield of 6.43, LINE has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.00, LINE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.01%

5.2 History

LINE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LINE Yearly Dividends per shareLINE Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y35.99%
EPS Next 3Y23.03%
LINE Yearly Income VS Free CF VS DividendLINE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 -200M -400M -600M

LINEAGE INC

NASDAQ:LINE (12/31/2025, 8:12:11 PM)

After market: 35 0 (0%)

35

-0.52 (-1.46%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-24 2026-02-24
Inst Owners33.48%
Inst Owner Change2.47%
Ins Owners0.2%
Ins Owner Change-0.73%
Market Cap7.99B
Revenue(TTM)5.36B
Net Income(TTM)-137.00M
Analysts68.8
Price Target43.41 (24.03%)
Short Float %12.32%
Short Ratio5.56
Dividend
Industry RankSector Rank
Dividend Yield 6.01%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-225.11%
Min EPS beat(2)-404.2%
Max EPS beat(2)-46.03%
EPS beat(4)0
Avg EPS beat(4)-238.04%
Min EPS beat(4)-466.27%
Max EPS beat(4)-35.66%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.06%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-2.46%
Min Revenue beat(4)-5.42%
Max Revenue beat(4)-0.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.49%
PT rev (3m)-14.59%
EPS NQ rev (1m)-200%
EPS NQ rev (3m)-642.3%
EPS NY rev (1m)-136.36%
EPS NY rev (3m)-664.71%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-1.19%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.49
P/FCF 47
P/OCF 9.04
P/B 0.95
P/tB 2.11
EV/EBITDA 13.34
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)0.74
FCFY2.13%
OCF(TTM)3.87
OCFY11.06%
SpS23.47
BVpS36.72
TBVpS16.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -1.63%
ROCE 1.31%
ROIC 1.04%
ROICexc 1.04%
ROICexgc 1.4%
OM 4.39%
PM (TTM) N/A
GM 32.18%
FCFM 3.17%
ROA(3y)-1.51%
ROA(5y)N/A
ROE(3y)-3.64%
ROE(5y)N/A
ROIC(3y)1.85%
ROIC(5y)N/A
ROICexc(3y)1.86%
ROICexc(5y)N/A
ROICexgc(3y)2.54%
ROICexgc(5y)N/A
ROCE(3y)2.34%
ROCE(5y)N/A
ROICexgc growth 3Y8.4%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.9%
ROICexc growth 5YN/A
OM growth 3Y0.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 42.62
Debt/EBITDA 6.29
Cap/Depr 79.16%
Cap/Sales 13.33%
Interest Coverage 0.77
Cash Conversion 77.75%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.86
Altman-Z 0.59
F-Score4
WACC7.18%
ROIC/WACC0.14
Cap/Depr(3y)99.91%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.25%
EPS Next Y76.7%
EPS Next 2Y35.99%
EPS Next 3Y23.03%
EPS Next 5Y17.73%
Revenue 1Y (TTM)-42.65%
Revenue growth 3Y12.99%
Revenue growth 5YN/A
Sales Q2Q%3.15%
Revenue Next Year1.18%
Revenue Next 2Y1.97%
Revenue Next 3Y2.77%
Revenue Next 5Y6.68%
EBIT growth 1Y-70.07%
EBIT growth 3Y13.12%
EBIT growth 5YN/A
EBIT Next Year377.64%
EBIT Next 3Y74.24%
EBIT Next 5Y56.23%
FCF growth 1Y-59.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.58%
OCF growth 3Y28.68%
OCF growth 5YN/A

LINEAGE INC / LINE FAQ

What is the fundamental rating for LINE stock?

ChartMill assigns a fundamental rating of 2 / 10 to LINE.


What is the valuation status for LINE stock?

ChartMill assigns a valuation rating of 2 / 10 to LINEAGE INC (LINE). This can be considered as Overvalued.


How profitable is LINEAGE INC (LINE) stock?

LINEAGE INC (LINE) has a profitability rating of 1 / 10.


How financially healthy is LINEAGE INC?

The financial health rating of LINEAGE INC (LINE) is 3 / 10.